Unveiling the Layers of Nonclinical Dermal Studies


 

In this issue of The Altascientist, we review the specific nonclinical requirements to move a dermal program forward to Phase I clinical trials and how to minimize inherent challenges―a case study using the minipig model is included.

 

READ THE ISSUE

 

Considerations for nonclinical dermal studies - Advancing to phase 1

 

Altasciences has decades of experience supporting dermal drug development programs, from initial efficacy to clinical proof of concept. We boast one of North America's largest herds of miniature swine, including the most popular breeds of minipigs for dermal studies.

 

Speak with one of our experts today and let's get your program underway.

 

 

​​Related resources that may interest you:

    •   Webpage: Preclinical Research Services
    •   eBook: Scratching the Surface of Nonclinical Dermal Testing
    •   Webinar: Downsized Miniature Swine―A New Spin on the Oldest Model